Emily Jane Cook

Emily Cook is a practice area leader for McDermott's Healthcare Regulatory & Compliance practice. She is a national authority on the 340B drug pricing program, and also helps clients navigate the full suite of federal and state regulations that are essential to healthcare operations. Learn more about Emily's practice: https://www.mwe.com/people/cook-emily-j/
This Week in 340B: March 14 – 20, 2023
By Emily Jane Cook, Reuben Bank, Ming Chuang and Kelsey Reinhardt on Mar 22, 2023
Posted In 340B
This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation....
Continue Reading
This Week in 340B: March 7 – 13, 2023
By Emily Jane Cook, Ming Chuang and Kelsey Reinhardt on Mar 15, 2023
Posted In 340B
This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation....
Continue Reading
Proposed Changes to DSH Payment Calculation Regulations Could Impact 340B Hospitals
By Emily Jane Cook, Caroline Reignley and Katie Waldo on Mar 10, 2023
Posted In 340B
On February 28, 2023, the Centers for Medicare and Medicaid Services (CMS) released a proposed rule that would change how Medicare disproportionate share hospital (DSH) payments are calculated with respect to the counting of days associated with Section 1115 demonstrations in the Medicaid fraction of the DSH calculation. This proposed rule is a follow-up to...
Continue Reading
This Week in 340B: February 28 – March 6, 2023
By Emily Jane Cook and Kelsey Reinhardt on Mar 8, 2023
Posted In 340B
This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation....
Continue Reading
This Week in 340B: February 21 – 27, 2023
By Emily Jane Cook, Ming Chuang and Kelsey Reinhardt on Feb 27, 2023
Posted In 340B
This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation....
Continue Reading
This Week in 340B: February 14 – 20, 2023
By Emily Jane Cook, Ming Chuang and Kelsey Reinhardt on Feb 21, 2023
Posted In 340B
This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation....
Continue Reading
This Week in 340B: February 7 – 13, 2023
By Emily Jane Cook, Reuben Bank and Kelsey Reinhardt on Feb 14, 2023
Posted In 340B
This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation....
Continue Reading
This Week in 340B: January 31 – February 6, 2023
By Emily Jane Cook, Reuben Bank and Kelsey Reinhardt on Feb 6, 2023
Posted In 340B, Uncategorized
This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation....
Continue Reading
340B Covered Entities May See Access Changes to Contrast Media, Radiopharmaceuticals and Other Products
By Emily Jane Cook and Anisa Mohanty on Feb 2, 2023
Posted In 340B
340B covered entities may experience expanded access to contrast media, radiopharmaceuticals and other products at 340B prices in the coming months. Buried in the over 1,600 pages of the Consolidated Appropriations Act, 2023 is a new law requiring the US Food and Drug Administration (FDA) to treat all contrast media, radiopharmaceuticals and over-the-counter (OTC) monograph...
Continue Reading
Court Rules in Favor of Manufacturers in 340B Contract Pharmacy Case
By Emily Jane Cook on Jan 31, 2023
Posted In 340B
Earlier today, the US Court of Appeals for the Third Circuit issued a much-anticipated decision in one of the 340B contract pharmacy cases. The decision is a win for drug manufacturers who have sought to restrict access to 340B prices on drugs dispensed through contract pharmacy arrangements. The Court found that the 340B statute does...
Continue Reading